GlassScriptPhysician profile
Suzanne L Leach
NPI 1386614782
$1,411.79
in general payments reported to CMS, 2019-2025
13 companies · $184 in 2025
The $184 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.37 · 2020: $135 · 2021: $124 · 2022: $226 · 2023: $279 · 2024: $381 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $844.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $843.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $502.46 | 2023-2025 | Miebo, Xiidra, Infuse |
| Novartis Pharmaceuticals Corporation | $272.63 | 2020-2023 | |
| Sun Pharmaceutical Industries INC. | $173.60 | 2019-2025 | Cequa |
| Alcon Vision LLC | $152.08 | 2019-2025 | Tryptyr |
| Oyster Point Pharma, INC. | $110.26 | 2023-2025 | Tyrvaya, Ryzumvi |
| Johnson & Johnson Vision Care, INC. | $45.81 | 2019-2020 | |
| Biotissue Holdings INC. | $45.65 | 2022-2025 | |
| Kala Pharmaceuticals, INC. | $33.23 | 2021 | |
| Harrow Eye, LLC | $21.21 | 2024 | Vevye |
| Allergan, INC. | $14.50 | 2020 | |
| Lkc Technologies, INC. | $13.60 | 2025 | |
| Tarsus Pharmaceuticals, INC. | $13.51 | 2025 | Xdemvy |
| Shire North American Group INC | $13.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Leach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.